Which hedge funds own ACRS? ACLARIS THERAPEUTICS INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
6 of the hedge funds tracked by WhaleCreep disclosed a position in ACRS (ACLARIS THERAPEUTICS INC) in their Q2 2026 13F filings, worth $94.4m in total. The largest holder by portfolio weight is RA Capital Management at 0.6% of its book. 1 exited: Marshall Wace.
6tracked managers holding
0opened this quarter
1exited this quarter
Which hedge funds hold ACRS? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| RA Capital Management | Q2 2026 | 0.6% | $67.3m | 12,723,026 | 87% | added |
| Woodline Partners | Q2 2026 | 0.0% | $8.5m | 1,611,054 | 8% | added |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $4.3m | 817,531 | 63% | added |
| Citadel Advisors | Q2 2026 | 0.0% | $9.3m | 1,762,081 | -22% | reduced |
| Millennium Management | Q2 2026 | 0.0% | $2.8m | 523,895 | -31% | reduced |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $2.2m | 414,499 | -54% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Marshall Wace | 0.1% | $2.7m |
How has hedge fund ownership of ACRS changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 6 | $94.4m |
| Q1 2026 | 7 | $50.3m |
| Q4 2025 | 3 | $5.9m |
| Q3 2025 | 1 | $3.1m |
| Q2 2025 | 1 | $2.1m |
| Q1 2025 | 2 | $8.6m |
| Q4 2024 | 2 | $13.7m |
| Q3 2024 | 2 | $1.6m |
| Q2 2024 | 2 | $1.1m |
| Q1 2024 | 2 | $2.1m |
| Q4 2023 | 2 | $1.9m |
| Q3 2023 | 5 | $40.5m |
| Q2 2023 | 6 | $90.5m |
| Q1 2023 | 6 | $70.7m |
| Q4 2022 | 5 | $150.7m |
| Q3 2022 | 5 | $160.5m |
Counts every tracked manager that disclosed ACRS in that quarter's filing, including managers that have since stopped filing.